NEUROCRINE BIOSCIENCES INC (NBIX) has 18 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $345K. Most recent filing: Sept. 15, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 15, 2026 filed Sept. 11, 2026 | Onyia Jude Chief Scientific Officer | — | +1,651 | +8% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Lippoldt Darin Chief Legal Officer | — | +2,064 | +4% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Keswani Sanjay Chandru Chief Medical Officer | — | +1,802 | +122% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | GORMAN KEVIN CHARLES Director | — | +6,504 | +1% | No | |
|
|
||||||
| Sept. 15, 2026 filed Sept. 11, 2026 | Gano Kyle Chief Executive Officer | — | +3,737 | +2% | No | |
|
|
||||||
Showing the 5 most recent of 18 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free